Table 3.
Breakdown of repeated onabotulinumtoxinA injections and reasons for discontinuation
| Injections, no | 1 | 2 | 3 | 4 | 5 | 6 | 8 |
|---|---|---|---|---|---|---|---|
| Patients | 136 | 70 | 31 | 16 | 6 | 3 | 2 |
| Decided not to have further injection Reasons given for no further injection, no | 63 | 39 | 14 | 10 | 3 | 1 | 2 |
| Symptoms controlled | 27 | 18 | 9 | 5 | 2 | 1 | 1 |
| Worsening of SUI | 4 | 0 | 0 | 0 | 0 | 0 | 0 |
| Worsening of OAB | 2 | 1 | 1 | 0 | 0 | 0 | 0 |
| Loss of effect over time | 0 | 5 | 3 | 5 | 1 | 0 | 1 |
| Not significant improvement | 7 | 0 | 0 | 0 | 0 | 0 | 0 |
| LTFU | 9 | 4 | 0 | 0 | 0 | 0 | 0 |
| Waiting for a new injection | 3 | 0 | 1 | 0 | 0 | 0 | 0 |
LTFU = lost to follow-up, OAB = overactive bladder, SUI = stress urinary incontinence.